As of 2025-05-09, the EV/EBITDA ratio of Arcadia Biosciences Inc (RKDA) is -0.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RKDA's latest enterprise value is 1.64 mil USD. RKDA's TTM EBITDA according to its financial statements is -7.04 mil USD. Dividing these 2 quantities gives us the above RKDA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.2x - 7.3x | 4.9x |
| Forward P/E multiples | 4.8x - 6.5x | 5.9x |
| Fair Price | (21.48) - (30.12) | (24.67) |
| Upside | -600.8% - -802.2% | -675.1% |
| Date | EV/EBITDA |
| 2025-05-07 | -0.23 |
| 2025-05-06 | -0.25 |
| 2025-05-05 | -0.15 |
| 2025-05-02 | -0.08 |
| 2025-05-01 | -0.10 |
| 2025-04-30 | -0.08 |
| 2025-04-29 | -0.05 |
| 2025-04-28 | -0.07 |
| 2025-04-25 | -0.07 |
| 2025-04-24 | -0.03 |
| 2025-04-23 | 0.02 |
| 2025-04-22 | 0.01 |
| 2025-04-21 | 0.04 |
| 2025-04-17 | 0.03 |
| 2025-04-16 | -0.01 |
| 2025-04-15 | 0.03 |
| 2025-04-14 | -0.01 |
| 2025-04-11 | -0.02 |
| 2025-04-10 | 0.02 |
| 2025-04-09 | 0.03 |
| 2025-04-08 | 0.07 |
| 2025-04-07 | 0.06 |
| 2025-04-04 | 0.07 |
| 2025-04-03 | 0.06 |
| 2025-04-02 | 0.08 |
| 2025-04-01 | 0.03 |
| 2025-03-31 | 0.02 |
| 2025-03-28 | 0.02 |
| 2025-03-27 | -0.06 |
| 2025-03-26 | -0.04 |
| 2025-03-25 | -0.06 |
| 2025-03-24 | -0.01 |
| 2025-03-21 | -0.01 |
| 2025-03-20 | -0.04 |
| 2025-03-19 | -0.07 |
| 2025-03-18 | -0.04 |
| 2025-03-17 | -0.03 |
| 2025-03-14 | -0.03 |
| 2025-03-13 | -0.02 |
| 2025-03-12 | -0.05 |
| 2025-03-11 | -0.03 |
| 2025-03-10 | -0.03 |
| 2025-03-07 | -0.06 |
| 2025-03-06 | -0.07 |
| 2025-03-05 | -0.15 |
| 2025-03-04 | -0.14 |
| 2025-03-03 | -0.14 |
| 2025-02-28 | -0.16 |
| 2025-02-27 | -0.15 |
| 2025-02-26 | -0.14 |